Neurological problems no higher after vaccination; depression, anxiety risk tied to COVID severity

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Neurological risks not higher after COVID-19 vaccines

COVID-19 vaccination did not increase risks for rare neurological conditions among more than 8 million people who had received at least one dose of a vaccine from AstraZeneca , Pfizer/BioNTech, Moderna or Johnson & Johnson, according to researchers.